Edges in Network
| Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | SLC6A14 |
| Upstream (Parents) |
|---|
| (<<) ACTN3 → SLC6A14 |
| (<<) CHST2 → SLC6A14 |
| (<<) DYNC1LI2 → SLC6A14 |
| (<<) FERMT1 → SLC6A14 |
| (<<) FOXO3 → SLC6A14 |
| (<<) GNAI2 → SLC6A14 |
| (<<) GPR109B → SLC6A14 |
| (<<) HS3ST2 → SLC6A14 |
| (<<) KCNN4 → SLC6A14 |
| (<<) KLHL7 → SLC6A14 |
| (<<) KLK5 → SLC6A14 |
| (<<) KRT5 → SLC6A14 |
| (<<) KRT6B → SLC6A14 |
| (<<) LIPG → SLC6A14 |
| (<<) MAP3K14 → SLC6A14 |
| (<<) NFATC1 → SLC6A14 |
| (<<) PLA2R1 → SLC6A14 |
| (<<) PLCG2 → SLC6A14 |
| (<<) SMURF1 → SLC6A14 |
| (<<) SYNJ2 → SLC6A14 |
| (<<) TMPRSS11D → SLC6A14 |
| Downstream (Children) |
|---|
| SLC6A14 → ANKRD57 (>>) |
| SLC6A14 → ELF5 (>>) |
| SLC6A14 → EPHB6 (>>) |
| SLC6A14 → HSD17B2 (>>) |
| SLC6A14 → MPHOSPH6 (>>) |
| SLC6A14 → OBSCN (>>) |
| SLC6A14 → ORM1 (>>) |
| SLC6A14 → PLCG1 (>>) |
| SLC6A14 → PTGS1 (>>) |
| SLC6A14 → SOCS1 (>>) |
| SLC6A14 → SOD2 (>>) |
| SLC6A14 → SPINK1 (>>) |
| SLC6A14 → TM4SF1 (>>) |
